Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

NCT05817227 · clinicaltrials.gov ↗
RECRUITING
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

National Cancer Institute, Naples